110 related articles for article (PubMed ID: 29921069)
1. [Correlation between prognosis and IL-33 expression in head and neck squamous cell carcinoma].
Li HQ; Wen YH; Wen WP
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jun; 32(12):895-898. PubMed ID: 29921069
[No Abstract] [Full Text] [Related]
2. Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma.
Qian X; Wagner S; Ma C; Coordes A; Gekeler J; Klussmann JP; Hummel M; Kaufmann AM; Albers AE
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1151-8. PubMed ID: 24770634
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of IQGAP1 indicates poor prognosis in head and neck squamous cell carcinoma.
Wu CC; Li H; Xiao Y; Yang LL; Chen L; Deng WW; Wu L; Zhang WF; Sun ZJ
J Mol Histol; 2018 Aug; 49(4):389-398. PubMed ID: 29846864
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy.
De Schutter H; Landuyt W; Verbeken E; Goethals L; Hermans R; Nuyts S
BMC Cancer; 2005 Apr; 5():42. PubMed ID: 15847702
[TBL] [Abstract][Full Text] [Related]
5. LTBP2 is a prognostic marker in head and neck squamous cell carcinoma.
Han L; Tang MM; Xu X; Jiang B; Huang J; Feng X; Qiang J
Oncotarget; 2016 Jul; 7(29):45052-45059. PubMed ID: 27281608
[TBL] [Abstract][Full Text] [Related]
6. High expression of leucine zipper-EF-hand containing transmembrane protein 1 predicts poor prognosis in head and neck squamous cell carcinoma.
Chen L; Yang Y; Liu S; Piao L; Zhang Y; Lin Z; Li Z
Biomed Res Int; 2014; 2014():850316. PubMed ID: 24689060
[TBL] [Abstract][Full Text] [Related]
7. Biomarker quantification by multiplexed quantum dot technology for predicting lymph node metastasis and prognosis in head and neck cancer.
Hu Z; Qian G; Müller S; Xu J; Saba NF; Kim S; Chen Z; Jiang N; Wang D; Zhang H; Lane K; Hoyt C; Shin DM; Chen ZG
Oncotarget; 2016 Jul; 7(28):44676-44685. PubMed ID: 27172790
[TBL] [Abstract][Full Text] [Related]
8. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases.
Cortesina G; Martone T; Galeazzi E; Olivero M; De Stefani A; Bussi M; Valente G; Comoglio PM; Di Renzo MF
Int J Cancer; 2000 May; 89(3):286-92. PubMed ID: 10861506
[TBL] [Abstract][Full Text] [Related]
9. Prognostic molecular markers in head and neck squamous cell carcinoma in a New Zealand population: matrix metalloproteinase-2 and sialyl Lewis x antigen.
Gunawardena I; Arendse M; Jameson MB; Plank LD; Gregor RT
ANZ J Surg; 2015 Nov; 85(11):843-8. PubMed ID: 24171785
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker.
Kawakami M; Kawakami K; Kasperbauer JL; Hinkley LL; Tsukuda M; Strome SE; Puri RK
Clin Cancer Res; 2003 Dec; 9(17):6381-8. PubMed ID: 14695138
[TBL] [Abstract][Full Text] [Related]
11. [Desmocollin-1 significant correlated with the tumorigenesis and prognosis of HNSCC].
Kou F; Li F; Wang L; Yu D; Chen C; Chen SM; Xiao BK; Tao ZZ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(10):763-766. PubMed ID: 29798048
[No Abstract] [Full Text] [Related]
12. Downregulation of the circadian Period family genes is positively correlated with poor head and neck squamous cell carcinoma prognosis.
Li YY; Jin F; Zhou JJ; Yu F; Duan XF; He XY; Wang R; Wu WL; Long JH; Luo XL
Chronobiol Int; 2019 Dec; 36(12):1723-1732. PubMed ID: 31609143
[TBL] [Abstract][Full Text] [Related]
13. RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck.
Kleer CG; Teknos TN; Islam M; Marcus B; Lee JS; Pan Q; Merajver SD
Clin Cancer Res; 2006 Aug; 12(15):4485-90. PubMed ID: 16899593
[TBL] [Abstract][Full Text] [Related]
14. Vasohibin-1 as a Novel Prognostic Factor for Head and Neck Squamous Cell Carcinoma.
Torii C; Hida Y; Shindoh M; Akiyama K; Ohga N; Maishi N; Ohiro Y; Ono M; Totsuka Y; Kitagawa Y; Tei K; Sato Y; Hida K
Anticancer Res; 2017 Mar; 37(3):1219-1225. PubMed ID: 28314285
[TBL] [Abstract][Full Text] [Related]
15. Tissue expression, serum and salivary levels of IL-10 in patients with head and neck squamous cell carcinoma.
Hamzavi M; Tadbir AA; Rezvani G; Ashraf MJ; Fattahi MJ; Khademi B; Sardari Y; Jeirudi N
Asian Pac J Cancer Prev; 2013; 14(3):1681-5. PubMed ID: 23679256
[TBL] [Abstract][Full Text] [Related]
16. Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas.
Szentkúti G; Dános K; Brauswetter D; Kiszner G; Krenács T; Csákó L; Répássy G; Tamás L
Pathol Oncol Res; 2015 Jul; 21(3):643-50. PubMed ID: 25547827
[TBL] [Abstract][Full Text] [Related]
17. Junctional Adhesion Molecule-A in Head and Neck Squamous Cell Carcinoma.
Kurose M; Kakuki T; Takano K; Kondo A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Kohno T; Kojima T; Himi T
Adv Otorhinolaryngol; 2016; 77():92-7. PubMed ID: 27115511
[TBL] [Abstract][Full Text] [Related]
18. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
[TBL] [Abstract][Full Text] [Related]
19. PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.
Szczepanski MJ; DeLeo AB; Łuczak M; Molinska-Glura M; Misiak J; Szarzynska B; Dworacki G; Zagor M; Rozwadowska N; Kurpisz M; Krzeski A; Kruk-Zagajewska A; Kopec T; Banaszewski J; Whiteside TL
Oral Oncol; 2013 Feb; 49(2):144-51. PubMed ID: 22944049
[TBL] [Abstract][Full Text] [Related]
20. Significance of PD-L1 expression in pulmonary metastases from head and neck squamous cell carcinoma.
Okada S; Itoh K; Ishihara S; Shimada J; Kato D; Tsunezuka H; Miyata N; Hirano S; Teramukai S; Inoue M
Surg Oncol; 2018 Jun; 27(2):259-265. PubMed ID: 29937180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
